| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/16/2002 | US6372487 Polynucleotides encoding peptide release factor, prfC (RF-3), a GTP-binding protein |
| 04/16/2002 | US6372485 Automated microbiological testing apparatus and method therefor |
| 04/16/2002 | US6372478 Vaccine vehicles are useful for administration to mammalian hosts for purposes of immunization |
| 04/16/2002 | US6372456 In diagnosis methods for detecting central nervous system and immune system-related disorders and in therapy |
| 04/16/2002 | US6372454 Also vectors, host cells; screening methods for identifying agonists or antagonists of follistatin-3 activity; diagnostic methods for detecting reproductive system and cell differentiation disorders and treating these |
| 04/16/2002 | US6372450 Exposing cells suspension to a treatment solution comprising tetraacetic acid derivative, disposing the cells upon a surface of an examination slide wherein the cells have enhanced adherence to the surface of slide |
| 04/16/2002 | US6372446 Method of selectively determining a fungal biomass |
| 04/16/2002 | US6372445 Useful for labeling materials such as proteins or cells |
| 04/16/2002 | US6372444 SODD gene expression in cancer |
| 04/16/2002 | US6372442 Sample of body fluid is subjected to at least two distinct immunological assays, each using a different immunological binding partner, and a numerical index is formed representing the difference in results of assays |
| 04/16/2002 | US6372441 Detecting the expression of the variable exon v10 in the cd44 gene in a patient or in a sample obtained from a patient, wherein the expression of the variable exon v10 in the cd44 gene indicates hodgkin's lymphomas |
| 04/16/2002 | US6372440 Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses |
| 04/16/2002 | US6372439 By detecting the presence of metaplastic cells expressing spasmolytic peptide which have brunner's gland morphology in gastric tissues of the patient; kits |
| 04/16/2002 | US6372438 Obtaining transformed mammalian cells comprising a recombinant nucleic acid encoding a hpdgf-r polypeptide; incubating transformed mammalian cells with compound, and incubating witout compound; comparing activation in test cells |
| 04/16/2002 | US6372432 Taking sample of blood cells from subject; preparing nucleic acids from sample; hybridizing nucleic acids with nucleic acid library in order to obtain a hybridization profile, detecting presence of cancer or neurodegenerative disease |
| 04/16/2002 | US6372431 Mammalian toxicological response markers |
| 04/16/2002 | US6372426 Immunoassay for determining the avidity of immunoglobulins |
| 04/16/2002 | US6372423 For use in dioagnosis such as tests for diagnosing heparin-associated thrombocytopenia (hat), therapy |
| 04/16/2002 | US6372222 Antigenic group B Streptococcus type II and type III polysaccharide fragments having a 2, 5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
| 04/16/2002 | US6372215 Monoclonal antibodies to human CD6 |
| 04/16/2002 | US6372214 Antibodies specific for native PrPSc |
| 04/16/2002 | US6372183 Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same |
| 04/16/2002 | US6372106 Capillary electrophoresis method and apparatus for reducing peak broadening associated with the establishment of an electric field |
| 04/16/2002 | US6371331 Electronic apparatus for dispensing precise small quantities of fluid |
| 04/16/2002 | US6371147 Evaluation and regulation of the thermal power of a flow of combustible gas; characterization of a thermal mass flowmeter |
| 04/16/2002 | US6370973 Device for removing slag samples |
| 04/16/2002 | US6370962 Dynamic high speed tensile tester |
| 04/16/2002 | US6370947 Substrate surface analysis |
| 04/16/2002 | US6370946 High temperature diesel deposit tester |
| 04/16/2002 | US6370941 Gas sensor and gas sensor system |
| 04/16/2002 | US6370940 Apparatus for determining concentration of a gas |
| 04/16/2002 | CA2541348A1 Methods for assessing, improving, or maintaining urogenital health in postmenopausal women |
| 04/16/2002 | CA2353110A1 Method and system for designing proteins and protein backbone configurations |
| 04/16/2002 | CA2197304C Acetic anhydride activation for c-terminal protein sequencing |
| 04/16/2002 | CA2184195C Screening method for identifying ligands for target proteins |
| 04/16/2002 | CA2162710C Dyes designed for high sensitivity detection of double-stranded dna |
| 04/16/2002 | CA2046607C Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 04/16/2002 | CA2025516C Selective leach for oxides and therein-contained metals |
| 04/12/2002 | CA2358831A1 Gene expression monitoring using universal arrays |
| 04/12/2002 | CA2358652A1 Process for detecting biological molecules |
| 04/11/2002 | WO2002029503A2 Flexible protocol generator |
| 04/11/2002 | WO2002029418A1 Selective anxiolytic therapeutic agents |
| 04/11/2002 | WO2002029417A2 Dynamic visualization of expressed gene networks in living cells |
| 04/11/2002 | WO2002029416A2 Method for determining chemical reactivity |
| 04/11/2002 | WO2002029415A1 Allergen-microarray assay |
| 04/11/2002 | WO2002029414A2 A method for the quantitative determination of one or more compounds |
| 04/11/2002 | WO2002029412A2 Selective binding materials |
| 04/11/2002 | WO2002029411A2 Magnetic in situ dilution |
| 04/11/2002 | WO2002029410A2 Cells having a spectral signature, and methods of preparation and use thereof |
| 04/11/2002 | WO2002029409A2 Method of assaying pyrrole-containing biological compounds |
| 04/11/2002 | WO2002029408A2 Methods for diagnosing and treating huntington's disease |
| 04/11/2002 | WO2002029407A2 Dye-labelled peptide and its diagnostic use |
| 04/11/2002 | WO2002029406A1 Methods and devices for processing blood samples |
| 04/11/2002 | WO2002029405A2 Method for testing substances that have a lytic effect, system for carrying out and using said method |
| 04/11/2002 | WO2002029404A1 Methods for detecting vasculopathies and tumors |
| 04/11/2002 | WO2002029402A2 System for electrophysiological measurements |
| 04/11/2002 | WO2002029398A1 Non-destructive testing of fibrous members |
| 04/11/2002 | WO2002029386A1 Calorimetric method for determining the color of wine |
| 04/11/2002 | WO2002029381A2 Method for the analysis of abnormal particle populations |
| 04/11/2002 | WO2002029376A1 Method for determining the frictional properties of materials |
| 04/11/2002 | WO2002029118A1 A kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus |
| 04/11/2002 | WO2002029117A2 Methods and probes for detection and/or quantification of nucleic acid sequences |
| 04/11/2002 | WO2002029104A2 Tumor marker and methods of use |
| 04/11/2002 | WO2002029102A1 Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips |
| 04/11/2002 | WO2002029099A1 Method of screening physiologically active substance |
| 04/11/2002 | WO2002029098A2 Genetic factors affecting the outcome of viral infections |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029087A2 Use of lymphangiogenic agents to treat lymphatic disorders |
| 04/11/2002 | WO2002029086A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 04/11/2002 | WO2002029076A1 Methods and compositions for directed microwave chemistry |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029060A2 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | WO2002029059A2 Nogo receptor homologs |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029050A2 Regulation of human secretin receptor-like gpcr |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002029032A2 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| 04/11/2002 | WO2002029031A2 Isoprenoid-dependent ras anchorage (idra) proteins |
| 04/11/2002 | WO2002029023A1 Nicastrin protein |
| 04/11/2002 | WO2002029015A1 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor |
| 04/11/2002 | WO2002029012A1 Processes for clonal growth of hepatic progenitor cells |
| 04/11/2002 | WO2002029003A2 Massive parallel method for decoding dna and rna |
| 04/11/2002 | WO2002028997A2 Methods of isolating bipotent hepatic progenitor cells |
| 04/11/2002 | WO2002028996A1 Automated bioculture and bioculture experiments system |
| 04/11/2002 | WO2002028910A2 Geometrically efficient particle agglutination, particularly to detect low affinity binding |
| 04/11/2002 | WO2002028906A2 Regulation of human sphingosine kinase-like protein |
| 04/11/2002 | WO2002028902A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | WO2002028897A2 Human g-protein coupled receptor and uses thereof |
| 04/11/2002 | WO2002028892A1 Von willebrand factor-binding proteins from staphylococci |
| 04/11/2002 | WO2002028891A2 Listeria inocua, genome and applications |
| 04/11/2002 | WO2002028888A2 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same |
| 04/11/2002 | WO2002028879A1 Suppressor of human breast cancer cell growth |
| 04/11/2002 | WO2002028841A2 Reagents for labeling biomolecules having aldehyde or ketone moieties |
| 04/11/2002 | WO2002028611A1 Predicting behaviour of a moulded composite component |
| 04/11/2002 | WO2002028507A2 Electronic detection of interaction based on the interruption of flow |
| 04/11/2002 | WO2002028455A1 Medication delivery device with bended piston rod |
| 04/11/2002 | WO2002028434A2 Use of a ppar delta activator for treating inflammatory conditions |
| 04/11/2002 | WO2002028414A1 Compositions and methods for wt1 specific immunotherapy |